All together, these findings indicate that the syringeabililty of the formulation is inversely proportional to its viscosity. The difference in performance between the products can be explained by different excipients in their formula. Tryiglycerides, medium –chain, allows a less viscous formulation than other excipients. EFICUR® is the less viscous product providing a better syringeability. This high fluidity is a key factor on a parenteral treatment, allowing more animals to be treated in less time and causing less stress.